A phase II trial with rosiglitazone in liposarcoma patients.

Autor: Debrock, G.1 Guy.Debrock@zol.be, Vanhentenrijk, V.2, Sciot, R.2, Debiec-Rychter, M.3, Oyen, R.4, Van Oosterom, A.1
Zdroj: British Journal of Cancer. 10/20/2003, Vol. 89 Issue 8, p1409-1412. 4p.
Databáze: Academic Search Ultimate